Veradigm Inc (MDRX)

Featured in Small-Cap Stocks

Veradigm Inc. is a healthcare technology company whose common stock is listed on OTC Markets under the symbol MDRX. The company provides information technology solutions for healthcare providers, payers, and biopharma customers in the United States and internationally. Its portfolio includes practice management software, AI-based patient scheduling, electronic statements and payments, clearinghouse capabilities, revenue cycle and coding services, and electronic health records tools such as ePrescribe with EPCS, Veradigm EHR, and Practice Fusion EHR. Veradigm also serves network partners and life sciences clients with API connectivity, diagnostic ordering and result networks, patient engagement tools, risk adjustment and quality analytics, data exchange and coding solutions, clinical data registries, provider engagement services, care gap alerting, and real-world data and evidence analytics. The company was formerly known as Allscripts Healthcare Solutions, Inc., adopted the Veradigm name in January 2023, and is headquartered in Chicago, Illinois.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-MDRX
$6.50
35.4% Upside
Undervalued
Good
0.0%
July 30, 2026
523.2 M
Valuation • Fair Value

Veradigm Inc (OTC-MDRX) Fair Value by Valuation Model

Compare the primary fair value estimate for Veradigm Inc (OTC-MDRX) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Fair Value Confidence

Very low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

Not available

Data is currently unavailable.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

NM

Comparable-company valuation reference.

Analyst Price Target

$6.50

Analysts imply upside of 35.4%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Veradigm Inc (OTC-MDRX) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Veradigm Inc (OTC-MDRX)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

Not available

Data is currently unavailable.

Revenue Forecast

Not available

Data is currently unavailable.

EBITDA

0 K

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Veradigm Inc (OTC-MDRX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Veradigm Inc (OTC-MDRX)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

Not available

Data is currently unavailable.

Beneish M-Score

Not available

Data is currently unavailable.

Altman Z-Score

Not available

Data is currently unavailable.

FCF / Net Income

Not available

Data is currently unavailable.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Veradigm Inc (OTC-MDRX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Veradigm Inc (OTC-MDRX)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 30, 2026

Days to Earnings

9

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Veradigm Inc (OTC-MDRX), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Veradigm Inc (OTC-MDRX) Stock Forecast & Technical Outlook

Review Veradigm Inc (OTC-MDRX) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Veradigm Inc (OTC-MDRX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Veradigm Inc (OTC-MDRX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Veradigm Inc (OTC-MDRX) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Veradigm Inc (OTC-MDRX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Veradigm Inc (OTC-MDRX) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Veradigm Inc (OTC-MDRX)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Veradigm Inc (OTC-MDRX) has a Buy consensus, with 1 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 1
Sell 0
FAQ Fast Investor Answers

Veradigm Inc (OTC-MDRX) Stock FAQ

Quick answers about Veradigm Inc (OTC-MDRX) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
Not available
Data is currently unavailable
Valuation Rating
Not available
Classification is not available
Analyst Target
$6.50
Implied upside 35.4%
Financial Health
Good
Current financial-health read

A fair value estimate for Veradigm Inc (OTC-MDRX) is not currently available in the latest data file.

A clear undervalued or overvalued classification is not currently available in the latest data file.

The available analyst price target for Veradigm Inc (OTC-MDRX) is $6.50. The analyst target implies estimated upside of 35.4%.

The current financial health read for Veradigm Inc (OTC-MDRX) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Veradigm Inc (OTC-MDRX) is July 30, 2026.

Based on the current data, dividend yield is 0.0%.

The current market capitalization listed for Veradigm Inc is 523.2 M.

The ticker symbol for Veradigm Inc is OTC-MDRX, and the stock is listed on OTC Markets.

Veradigm Inc (OTC-MDRX) is listed on OTC Markets.